These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 30099258

  • 1. Design, synthesis and characterization of potent microtubule inhibitors with dual anti-proliferative and anti-angiogenic activities.
    Zhang H, Fang X, Meng Q, Mao Y, Xu Y, Fan T, An J, Huang Z.
    Eur J Med Chem; 2018 Sep 05; 157():380-396. PubMed ID: 30099258
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors.
    Shuai W, Li X, Li W, Xu F, Lu L, Yao H, Yang L, Zhu H, Xu S, Zhu Z, Xu J.
    Eur J Med Chem; 2020 Jul 01; 197():112308. PubMed ID: 32339853
    [Abstract] [Full Text] [Related]

  • 3. Angiogenesis and anti-leukaemia activity of novel indole derivatives as potent colchicine binding site inhibitors.
    Yao Y, Huang T, Wang Y, Wang L, Feng S, Cheng W, Yang L, Duan Y.
    J Enzyme Inhib Med Chem; 2022 Dec 01; 37(1):652-665. PubMed ID: 35109719
    [Abstract] [Full Text] [Related]

  • 4. Discovery of novel vinyl sulfone derivatives as anti-tumor agents with microtubule polymerization inhibitory and vascular disrupting activities.
    Li W, Yin Y, Yao H, Shuai W, Sun H, Xu S, Liu J, Yao H, Zhu Z, Xu J.
    Eur J Med Chem; 2018 Sep 05; 157():1068-1080. PubMed ID: 30176537
    [Abstract] [Full Text] [Related]

  • 5. Synthesis, biological evaluation, and molecular docking investigation of 3-amidoindoles as potent tubulin polymerization inhibitors.
    Chen P, Zhuang YX, Diao PC, Yang F, Wu SY, Lv L, You WW, Zhao PL.
    Eur J Med Chem; 2019 Jan 15; 162():525-533. PubMed ID: 30472600
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biological evaluation of new 2-methoxyestradiol derivatives: Potent inhibitors of angiogenesis and tubulin polymerization.
    Sun M, Zhang Y, Qin J, Ba M, Yao Y, Duan Y, Liu H, Yu D.
    Bioorg Chem; 2021 Aug 15; 113():104988. PubMed ID: 34034135
    [Abstract] [Full Text] [Related]

  • 7. Synthesis and biological evaluation of carbamates derived from aminocombretastatin A-4 as vascular disrupting agents.
    Conesa-Milián L, Falomir E, Murga J, Carda M, Meyen E, Liekens S, Alberto Marco J.
    Eur J Med Chem; 2018 Mar 10; 147():183-193. PubMed ID: 29432949
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
    Stefański T, Mikstacka R, Kurczab R, Dutkiewicz Z, Kucińska M, Murias M, Zielińska-Przyjemska M, Cichocki M, Teubert A, Kaczmarek M, Hogendorf A, Sobiak S.
    Eur J Med Chem; 2018 Jan 20; 144():797-816. PubMed ID: 29291446
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents.
    Kim ND, Park ES, Kim YH, Moon SK, Lee SS, Ahn SK, Yu DY, No KT, Kim KH.
    Bioorg Med Chem; 2010 Oct 01; 18(19):7092-100. PubMed ID: 20810285
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, molecular properties prediction and biological evaluation of indole-vinyl sulfone derivatives as novel tubulin polymerization inhibitors targeting the colchicine binding site.
    Li W, Sun H, Xu F, Shuai W, Liu J, Xu S, Yao H, Ma C, Zhu Z, Xu J.
    Bioorg Chem; 2019 Apr 01; 85():49-59. PubMed ID: 30599412
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agents.
    Zhang X, Raghavan S, Ihnat M, Hamel E, Zammiello C, Bastian A, Mooberry SL, Gangjee A.
    Bioorg Med Chem; 2015 May 15; 23(10):2408-23. PubMed ID: 25882519
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis and biological evaluation of pyridine-chalcone derivatives as novel microtubule-destabilizing agents.
    Xu F, Li W, Shuai W, Yang L, Bi Y, Ma C, Yao H, Xu S, Zhu Z, Xu J.
    Eur J Med Chem; 2019 Jul 01; 173():1-14. PubMed ID: 30981112
    [Abstract] [Full Text] [Related]

  • 15. Design, synthesis and molecular modeling of new 4-phenylcoumarin derivatives as tubulin polymerization inhibitors targeting MCF-7 breast cancer cells.
    Batran RZ, Kassem AF, Abbas EMH, Elseginy SA, Mounier MM.
    Bioorg Med Chem; 2018 Jul 23; 26(12):3474-3490. PubMed ID: 29793751
    [Abstract] [Full Text] [Related]

  • 16. A novel microtubule depolymerizing colchicine analogue triggers apoptosis and autophagy in HCT-116 colon cancer cells.
    Kumar A, Singh B, Sharma PR, Bharate SB, Saxena AK, Mondhe DM.
    Cell Biochem Funct; 2016 Mar 23; 34(2):69-81. PubMed ID: 26919061
    [Abstract] [Full Text] [Related]

  • 17. Identification of novel and potent small-molecule inhibitors of tubulin with antitumor activities by virtual screening and biological evaluations.
    Liu G, Jiao Y, Huang C, Chang P.
    J Comput Aided Mol Des; 2019 Jul 23; 33(7):659-664. PubMed ID: 31165955
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Design, synthesis and biological evaluation of a novel tubulin inhibitor 7a3 targeting the colchicine binding site.
    Lai Q, Wang Y, Wang R, Lai W, Tang L, Tao Y, Liu Y, Zhang R, Huang L, Xiang H, Zeng S, Gou L, Chen H, Yao Y, Yang J.
    Eur J Med Chem; 2018 Aug 05; 156():162-179. PubMed ID: 30006162
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and biological evaluation of novel pyrazoline-containing derivatives as potential tubulin assembling inhibitors.
    Qin YJ, Li YJ, Jiang AQ, Yang MR, Zhu QZ, Dong H, Zhu HL.
    Eur J Med Chem; 2015 Apr 13; 94():447-57. PubMed ID: 25828827
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.